Logo

Pathway Genomics Gets FDA Registration for Collection Kit

Sep 28, 2011

NEW YORK (GenomeWeb News) – Pathway Genomics today said that the US Food and Drug Administration has classified and registered its saliva collection kit as a Class I exempt device.

The device is used to collect samples for the firm's genetic testing services.

The San Diego-based firm said last week that it had received a CLIA Certificate of Accreditation for its lab from the US Department of Health and Human Services' Centers for Medicare and Medicaid. It also recently received accreditation last month from the College of American Pathologists.

Filed under

PCR
Diagnostics
Tools & Technology
Regulatory News & FDA Approvals
FDA submission
FDA
genetic testing
sample collection kits
Pathway Genomics
Breaking News
The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.
What's Popular?

  1. Pushed a Bit Later